• Home
  • NEW DAY MEDICINE
  • 9 (71) 2024
  • 24 -9 (71) 2024 - Bayjanov A.K., Khikmatullaeva А.S., Abdukadirova M.A., Ibadullaeva N.S., Brigida K.S., Mirraximova N.M. - ANALYSIS OF FIBROMARKER PIIINP IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND LIVER CIRRHOSIS OF HBV ETIOLOGY

24 -9 (71) 2024 - Bayjanov A.K., Khikmatullaeva А.S., Abdukadirova M.A., Ibadullaeva N.S., Brigida K.S., Mirraximova N.M. - ANALYSIS OF FIBROMARKER PIIINP IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND LIVER CIRRHOSIS OF HBV ETIOLOGY

ANALYSIS OF FIBROMARKER PIIINP IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND LIVER CIRRHOSIS OF HBV ETIOLOGY

Bayjanov A.K. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Khikmatullaeva А.S. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Abdukadirova M.A. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Abdukadirova M.A. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Khikmatullaeva А.S. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Khikmatullaeva А.S. - The Research Institute of Virology of the Republican specialized scientific practical medical center of epidemiology, microbiology, infectious and parasitic diseases

Resume

This article highlights the importance of C-reactive protein (CRP) and procalcitonin (PCT), and cytokines in determining the prognosis of SARS-CoV-2-associated pneumonia. The article discusses the methods used to measure these biomarkers and the results of studies that have investigated their use in predicting the severity and outcome of SARS-CoV-2-associated pneumonia.

Keywords: SARS-CoV-2, pneumonia, C-reactive protein, procalcitonin, cytokines, biomarkers, prognosis.

First page

122

Last page

127

For citation:Bayjanov A.K., Khikmatullaeva А.S., Abdukadirova M.A., Ibadullaeva N.S., Brigida K.S., Mirraximova N.M. - ANALYSIS OF FIBROMARKER PIIINP IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B AND LIVER CIRRHOSIS OF HBV ETIOLOGY//New Day in Medicine 9(71)2024 122-127 https://newdayworldmedicine.com/en/new_day_medicine/9-71-2024

List of References

  1. Мехтиев С. Н. Фиброз печени как показание для терапии у больных хроническими гепатитами //Эффективная фармакотерапия. Гастроэнтерология, 2015;1(2):53.
  2. Мусин А.Г., Муталова Э.Г., Нигматуллина А.Э. Современные аспекты механизмов фиброгенеза в печени //Медицинский вестник Башкортостана. М., 2014;9(3):95-99.
  3. Пирогова И.Ю. Скорость регресса фиброза печени после успешной противовирусной терапии при хронической HBV-и HCV-инфекции //Материалы Х1Х Российского конгресса «Гепатология сегодня». - М., 2014;30.
  4. Рудой А.С., Черныш О.В. Метаболический синдром: современный взгляд на проблему //Военная медицина. 2016;1(38):107-114.
  5. Ткач С.М., Пучков К.С., Кузенко Ю.Г. Современные взгляды на патогенез фиброза печени и возможности его терапии //Сучасна гастроентерологія. - Киев, 2013;5(73):131-140.
  6. Цыркунов В.М., Андреев В.П., Кравчук Р.И. Клиническая цитология печени: звездчатые клетки Ито //Журнал Гродненского государственно медицинского университета. М., 2016;4(56):90-99.
  7. Cicoira M., Rossi A., Bonapace S. et al. Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure //J. Card. Fail., 2004;10:403-411.
  8. Chu, Chia-Ming, and Yun-Fan Liaw. "Natural histоry оf hepatitis B virus infectiоn." Hepatitis B Virus in Human Diseases //Humana Press, Cham, 2016;217-247.
  9. Kwo P.Y., Cohen S.M., Lim J.K. ACG clinical guideline: evaluation of abnormal liver chemistries //Am. J. Gastroenterol., 2017;112(1):18-35.
  10. Lippi G., Favaloro E. J. Laboratory hemostasis: from biology to the bench //Clin Chem Lab Med., 2018;56:1035-1045.
  11. Neuman M.G., Cohen L.B., Nanau R.M. Hyaluronic acid as a non-invasive biomarker of liver fibrosis //Clinical biochemistry, 2016;49(3):302-315.
  12. Quilliot D., Alla F., Bohme P. et al. Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance //Int J Obes Relat Metab Disord., 2005;29:1321-1328.
  13. Rostami S., Parsian H. Hyaluronic acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis //Hepat. Mon, 2013;13:1-9.
  14. Thiele M., Madsen B. S., Hansen J. F. et al. Accuracy of the enhanced liver fibrosis test vs fibrotest, electrography and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease //Gastroenterology, 2018;154(5):1369-1379.
  15. Torras X. et al. Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients //J. Gastroenterol., 2020;55(2):205-216.
  16. Tzartzeva, Kristina, et al. "Surveillance imaging and alpha fetоprоtein fоr early detectiоn оf hepatоcellular carcinоma in patients with cirrhоsis: a meta-analysis" //Gastrоenterоlоgy, 2018;154(6):1706-1718.
  17. Wang, Kang, et al. "Serum LncRNAs prоfiles serve as nоvel pоtential biоmarkers fоr the diagnоsis оf HBV-pоsitive hepatоcellular carcinоma" //PlоS оne, 2015;10(12):1-15.

    file

    download